{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:49:29Z","timestamp":1775710169741,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s13318-016-0352-3","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:24:17Z","timestamp":1465777457000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic Properties of Dapoxetine and Midazolam in Healthy Subjects"],"prefix":"10.1007","volume":"42","author":[{"given":"Khaled S.","family":"Abdlekawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Donia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawzy","family":"Elbarbry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"issue":"Suppl 1","key":"352_CR1","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1038\/sj.ijir.3900487","volume":"11","author":"EO Laumann","year":"1999","unstructured":"Laumann EO, Paik A, Rosen RC. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res. 1999;11(Suppl 1):S60\u20134.","journal-title":"Int J Impot Res"},{"issue":"5","key":"352_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/CMRH.S7337","volume":"2","author":"CG McMahon","year":"2011","unstructured":"McMahon CG. Efficacy of dapoxetine in the treatment of premature ejaculation. Clin Med Insights Reprod Health. 2011;2(5):25\u201339.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"9","key":"352_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0091270006291033","volume":"46","author":"MJ Dresser","year":"2006","unstructured":"Dresser MJ, Kang D, Staehr P, Gidwani S, Guo C, Mulhall JP, et al. Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: impact of age and effects of a high-fat meal. J Clin Pharmacol. 2006;46(9):1023\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"352_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/DMDI.2009.24.1.17","volume":"24","author":"S Wanwimolruk","year":"2009","unstructured":"Wanwimolruk S, Wong K, Wanwimolruk P. Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol Drug Interact. 2009;24(1):17\u201335.","journal-title":"Drug Metabol Drug Interact"},{"issue":"2","key":"352_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2012.08.001","volume":"136","author":"CS Won","year":"2012","unstructured":"Won CS, Oberlies NH, Paine MF. Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport. Pharmacol Ther. 2012;136(2):186\u2013201.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"352_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3945\/an.114.005728","volume":"6","author":"DA Hyson","year":"2015","unstructured":"Hyson DA. A review and critical analysis of the scientific literature related to 100\u00a0% fruit juice and human health. Adv Nutr. 2015;6(1):37\u201351.","journal-title":"Adv Nutr"},{"issue":"3","key":"352_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1517\/17425255.2011.553189","volume":"7","author":"MJ Hanley","year":"2011","unstructured":"Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol. 2011;7(3):267\u201386.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"352_CR8","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3402\/fnr.v58.22179","volume":"58","author":"MM Murphy","year":"2014","unstructured":"Murphy MM, Barraj LM, Rampersaud GC. Consumption of grapefruit is associated with higher nutrient intakes and diet quality among adults, and more favorable anthropometrics in women, NHANES 2003\u20132008. Food Nutr Res. 2014;58:1654\u201361.","journal-title":"Food Nutr Res"},{"issue":"6","key":"352_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/clpt.1993.195","volume":"54","author":"DG Bailey","year":"1993","unstructured":"Bailey DG, Arnold JM, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther. 1993;54(6):589\u201394.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"352_CR10","first-page":"885","volume":"114","author":"M Cuciureanu","year":"2010","unstructured":"Cuciureanu M, Vlase L, Muntean D, Varlan I, Cuciureanu R. Grapefruit juice\u2013drug interactions: importance for pharmacotherapy. Rev Med Chir Soc Med Nat Iasi. 2010;114(3):885\u201391.","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"8","key":"352_CR11","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.fct.2009.05.004","volume":"47","author":"K Strauch","year":"2009","unstructured":"Strauch K, Lutz U, Bittner N, Lutz WK. Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food Chem Toxicol. 2009;47(8):1928\u201335.","journal-title":"Food Chem Toxicol"},{"issue":"7269","key":"352_CR12","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/bmj.321.7269.1153","volume":"321","author":"P Langley","year":"2000","unstructured":"Langley P. Why a pomegranate? BMJ. 2000;321(7269):1153\u20134.","journal-title":"BMJ"},{"issue":"10","key":"352_CR13","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1021\/jf000404a","volume":"48","author":"MI Gil","year":"2000","unstructured":"Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000;48(10):4581\u20139.","journal-title":"J Agric Food Chem"},{"issue":"6","key":"352_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1124\/dmd.110.032094","volume":"38","author":"RS Foti","year":"2010","unstructured":"Foti RS, Rock DA, Wienkers LC, Wahlstrom JL. Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation. Drug Metab Dispos. 2010;38(6):981\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"352_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10928-008-9104-6","volume":"35","author":"M Chenel","year":"2008","unstructured":"Chenel M, Bouzom F, Aarons L, Ogungbenro K. Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDes. J Pharmacokinet Pharmacodyn. 2008;35(6):635\u201359.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"352_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10928-008-9105-5","volume":"35","author":"M Chenel","year":"2008","unstructured":"Chenel M, Bouzom F, Cazade F, Ogungbenro K, Aarons L, Mentre F. Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results. J Pharmacokinet Pharmacodyn. 2008;35(6):661\u201381.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"352_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1124\/jpet.104.076836","volume":"312","author":"MF Paine","year":"2005","unstructured":"Paine MF, Criss AB, Watkins PB. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition. J Pharmacol Exp Ther. 2005;312(3):1151\u201360.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"352_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/bcp.12581","volume":"80","author":"MT Holmberg","year":"2015","unstructured":"Holmberg MT, Tornio A, Hyvarinen H, Neuvonen M, Neuvonen PJ, Backman JT, et al. Effect of grapefruit juice on the bioactivation of prasugrel. Br J Clin Pharmacol. 2015;80(1):139\u201345.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"352_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/bcp.12026","volume":"75","author":"MT Holmberg","year":"2013","unstructured":"Holmberg MT, Tornio A, Joutsi-Korhonen L, Neuvonen M, Neuvonen PJ, Lassila R, et al. Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects. Br J Clin Pharmacol. 2013;75(6):1488\u201396.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"352_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.0306-5251.2001.01473.x","volume":"52","author":"Z Desta","year":"2001","unstructured":"Desta Z, Kivisto KT, Lilja JJ, Backman JT, Soukhova N, Neuvonen PJ, et al. Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice. Br J Clin Pharmacol. 2001;52(4):399\u2013407.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"352_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2133\/dmpk.DMPK-12-RG-067","volume":"28","author":"M Hu","year":"2013","unstructured":"Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Effects of grapefruit juice and SLCO1B1 388A>G polymorphism on the pharmacokinetics of pitavastatin. Drug Metab Pharmacokinet. 2013;28(2):104\u20138.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"352_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.amjmed.2015.07.036","volume":"129","author":"JW Lee","year":"2016","unstructured":"Lee JW, Morris JK, Wald NJ. Grapefruit juice and statins. Am J Med. 2016;129(1):26\u20139.","journal-title":"Am J Med"},{"issue":"4","key":"352_CR23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ajcn\/87.4.863","volume":"87","author":"MF Paine","year":"2008","unstructured":"Paine MF, Widmer WW, Pusek SN, Beavers KL, Criss AB, Snyder J, et al. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr. 2008;87(4):863\u201371.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"352_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1124\/dmd.104.002824","volume":"33","author":"M Hidaka","year":"2005","unstructured":"Hidaka M, Okumura M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, et al. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metab Dispos. 2005;33(5):644\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"352_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/ptr.3704","volume":"26","author":"S Voruganti","year":"2012","unstructured":"Voruganti S, Yamsani SK, Ravula SK, Gannu R, Yamsani MR. Effect of pomegranate juice on intestinal transport and pharmacokinetics of nitrendipine in rats. Phytother Res. 2012;26(8):1240\u20135.","journal-title":"Phytother Res"},{"issue":"1","key":"352_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1021\/jf010865b","volume":"50","author":"RP Singh","year":"2002","unstructured":"Singh RP, ChidambaraMurthy KN, Jayaprakasha GK. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. J Agric Food Chem. 2002;50(1):81\u20136.","journal-title":"J Agric Food Chem"},{"issue":"8","key":"352_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2165\/00003088-200746080-00005","volume":"46","author":"Y Ohno","year":"2007","unstructured":"Ohno Y, Hisaka A, Suzuki H. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs. Clin Pharmacokinet. 2007;46(8):681\u201396.","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-016-0352-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0352-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0352-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0352-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T13:02:20Z","timestamp":1568034140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-016-0352-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1007\/s13318-016-0352-3","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}